HQD: Leading Sales of Pod-System in Russia, to Launch New Screen-Display Vape in 2024

InnovationBusiness by 2FIRSTS
Dec.20.2023
HQD: Leading Sales of Pod-System in Russia, to Launch New Screen-Display Vape in 2024
HQD, a leading e-cigarette brand, showcased its latest product, a screen-display e-cigarette, at the VAPE CLUB SHOW 2023 in Russia.

During the VAPE CLUB SHOW 2023, a Russian e-cigarette exhibition held on December 16th and 17th, 2FIRSTS engaged in a conversation with Mark, the business manager responsible for the distribution of HQD in Russia. The purpose was to gain insights into the current status and future plans of HQD in the Russian market.

HQD: Leading Sales of Pod-System in Russia, to Launch New Screen-Display Vape in 2024
 HQD's new e-cigarette model with a built-in display screen | Image source: 2FIRSTS

 

HQD showcased multiple new products at the exhibition. One of these products, a screen-display e-cigarette, was introduced by Mark. This latest offering from HQD is expected to be officially released next year. It is worth noting that screen-display e-cigarettes are currently very popular in the Russian market.

 

HQD: Leading Sales of Pod-System in Russia, to Launch New Screen-Display Vape in 2024
HQD ULTIMA PRO is the best-selling product of HQD in Russia | Image source: 2FIRSTS

 

Mark, a spokesperson for HQD, recently commented on the company's successful products in the Russian market. According to Mark, HQD has a range of popular products, with the best-selling item being the "HQD ULTIMA PRO." This particular product boasts an impressive 10,000 puffs and offers a smoother smoking experience. Another notable product is the "HQD Click," which is a refillable device and ranks among the top three best-selling items in the HQD product line.

 

Regarding the e-cigarette market in Russia and the comprehensive e-cigarette regulation policy implemented in the country this year, Mark emphasizes that HQD has always been strictly abiding by the legal requirements. However, he points out that due to the existence of a considerable percentage of the "gray" market in Russia, not only does it violate the principles of fair competition, but it also negatively affects HQD's market share. Mark states that this is a problem commonly seen in the industry, but HQD remains optimistic about the future.

 

Mark further expressed that although the e-cigarette industry is currently facing a series of challenges, HQD firmly believes that, just like the alcohol industry once did, the e-cigarette industry will also experience improvement in the coming years. This is why HQD started the company's transformation and adaptation process even before the implementation of regulatory policies.

 

Finally, Mark shared HQD's plans for the Russian market next year. He emphasized that the main task of the coming year is to ensure that all partners' distribution networks can fully adapt to the new regulatory changes. This initiative aims to ensure HQD's sustained growth in the Russian market and create more opportunities for the future.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
Wang Gongcheng, deputy administrator of China’s State Tobacco Monopoly Administration, met KT&G Chief Operating Officer Lee Sang-hak in Shanghai on September 1, according to Oriental Tobacco News. The meeting comes as China seeks public comment on a draft mandatory national standard for heated cigarettes. The report did not disclose the subjects discussed or indicate whether heated tobacco products or market access were addressed.
News
Sep.02
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10